60 related articles for article (PubMed ID: 18989889)
1. Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients.
Tay N; Laakso EL; Schweitzer D; Endersby R; Vetter I; Starobova H
Front Mol Biosci; 2022; 9():1015746. PubMed ID: 36310587
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors.
Gagliardi A; Giuliano E; Venkateswararao E; Fresta M; Bulotta S; Awasthi V; Cosco D
Front Pharmacol; 2021; 12():601626. PubMed ID: 33613290
[TBL] [Abstract][Full Text] [Related]
3. Natural compounds for pediatric cancer treatment.
Ferrucci V; Boffa I; De Masi G; Zollo M
Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb; 389(2):131-49. PubMed ID: 26650503
[TBL] [Abstract][Full Text] [Related]
4. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
5. Ifosfamide in pediatric solid tumors.
Carli M; Passone E; Perilongo G; Bisogno G
Oncology; 2003; 65 Suppl 2():99-104. PubMed ID: 14586158
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of paclitaxel with standard dose ifosfamide in children with refractory solid tumors: a Pediatric Oncology Group study (POG 9376).
Geller JI; Wall D; Perentesis J; Blaney SM; Bernstein M;
Pediatr Blood Cancer; 2009 Mar; 52(3):346-50. PubMed ID: 18989889
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group Study.
Hurwitz CA; Relling MV; Weitman SD; Ravindranath Y; Vietti TJ; Strother DR; Ragab AH; Pratt CB
J Clin Oncol; 1993 Dec; 11(12):2324-9. PubMed ID: 7902425
[TBL] [Abstract][Full Text] [Related]
8. A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer.
Downs LS; Judson PL; Argenta PA; Carson LF; Boente MP
Gynecol Oncol; 2004 Nov; 95(2):347-51. PubMed ID: 15491756
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel by 72-hour continuous infusion followed by bolus intravenous ifosfamide or epirubicin: results of two phase I studies.
Miglietta L; Marenghi C; Nizzo R; Foglia G; Ragni N; Boccardo F
Oncology; 2001; 60(2):116-22. PubMed ID: 11244325
[TBL] [Abstract][Full Text] [Related]
10. A Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors.
Bunnell CA; Thompson L; Buswell L; Berkowitz R; Muto M; Sheets E; Shulman LN
Cancer; 1998 Feb; 82(3):561-6. PubMed ID: 9452275
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel, ifosfamide and cisplatin in solid tumour treatment: a phase I study.
Specenier P; Rasschaert M; Van den Brande J; Dyck J; Schrijvers D; Huizing MT; Vermorken JB
Anticancer Drugs; 2010 Mar; 21(3):306-12. PubMed ID: 20087171
[TBL] [Abstract][Full Text] [Related]
12. A Phase 1 and pharmacokinetic clinical trial of paclitaxel for the treatment of refractory leukemia in children: a Children's Oncology Group study.
Horton TM; Ames MM; Reid JM; Krailo MD; Pendergrass T; Mosher R; Reaman GH; Seibel NL;
Pediatr Blood Cancer; 2008 Apr; 50(4):788-92. PubMed ID: 17668866
[TBL] [Abstract][Full Text] [Related]
13. Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study.
Homesley HD; Filiaci V; Markman M; Bitterman P; Eaton L; Kilgore LC; Monk BJ; Ueland FR;
J Clin Oncol; 2007 Feb; 25(5):526-31. PubMed ID: 17290061
[TBL] [Abstract][Full Text] [Related]
14. Response to paclitaxel, topotecan, and topotecan-cyclophosphamide in children with untreated disseminated neuroblastoma treated in an upfront phase II investigational window: a pediatric oncology group study.
Kretschmar CS; Kletzel M; Murray K; Thorner P; Joshi V; Marcus R; Smith EI; London WB; Castleberry R
J Clin Oncol; 2004 Oct; 22(20):4119-26. PubMed ID: 15483021
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]